Lexicon Pharmaceuticals
LXRX
#7142
Rank
A$0.76 B
Marketcap
A$2.11
Share price
-1.41%
Change (1 day)
109.15%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - Total debt

Total debt on the balance sheet as of September 2025 : A$87.54 Million

According to Lexicon Pharmaceuticals 's latest financial reports the company's total debt is A$87.54 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Lexicon Pharmaceuticals - Total debt on balance sheet (from 2000 to 2025)

Total debt by year

Year Total debt Change
2024-12-31A$0.17 B11.94%
2023-12-31A$0.15 B91.59%
2022-12-31A$81.25 M2484.81%
2021-12-31A$3.14 M-81.13%
2020-12-31A$16.65 M-95.25%
2019-12-31A$0.35 B0.92%
2018-12-31A$0.34 B10.52%
2017-12-31A$0.31 B123.59%
2016-12-31A$0.14 B-0.4%
2015-12-31A$0.14 B7.41%
2014-12-31A$0.13 B436.4%
2013-12-31A$24.52 M8.68%
2012-12-31A$22.56 M-7.05%
2011-12-31A$24.27 M-13.42%
2010-12-31A$28.04 M-62.38%
2009-12-31A$74.54 M72.48%
2008-12-31A$43.21 M20.44%
2007-12-31A$35.88 M-12.12%
2006-12-31A$40.83 M-19.12%
2005-12-31A$50.48 M3.82%
2004-12-31A$48.62 M-35.85%
2003-12-31A$75.8 M967.68%
2002-12-31A$7.09 M
2000-12-31A$5.09 M-29.99%
1999-12-31A$7.27 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Eterna Therapeutics
ERNA
A$0.83 M-99.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$4.07 B 4,552.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
A$50.93 M-41.82%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.90 B 939.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
A$53.71 B 61,258.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A$0.46 B 427.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$3.87 B 4,329.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$0.67 B 675.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
A$0.50 B 479.51%๐Ÿ‡บ๐Ÿ‡ธ USA